• Return to Headlines

Highest EBITDA Growth in the Biotechnology Industry Detected in Shares of Biomarin Pharmac (BMRN, ALXN, CELG, RGEN, LGND)

By James Quinn

Below are the three companies in the Biotechnology industry with the highest EBITDA Growth (next year estimate vs. LTM). EBITDA Growth can be valuable in predicting future cash flow generation and earnings power.

Biomarin Pharmac ranks highest with a EBITDA growth of 156.0%. Alexion Pharm is next with a EBITDA growth of 121.4%. Celgene Corp ranks third highest with a EBITDA growth of 116.7%.

Repligen Corp follows with a EBITDA growth of 103.7%, and Ligand Pharm rounds out the top five with a EBITDA growth of 45.6%.

SmarTrend is tracking the current trend status for Biomarin Pharmac and will alert subscribers who have BMRN in their portfolio or watchlist when shares have changed trend direction.

Keywords: highest ebitda growth biomarin pharmac alexion pharm celgene corp repligen corp ligand pharm

Ticker(s): BMRN ALXN CELG RGEN LGND